The design, implementation and reporting of this study will conform to the guidelines listed in the ICH-GCP, Declaration of Helsinki, standard CONSORT 2010 Statement [ 69].
The study design complies with the Declaration of Helsinki ethical standards.
The Ethical and Scientific Committees of the Instituto Nacional de Câncer, Rio de Janeiro, Brazil approved the study (CEP-INCA 107/06) CEP-INCA 107/06inh the Declaccordance Helsinki ethical standards.
The study received approval from appropriate research ethics committees and was conducted in accordance with the Declaration of Helsinki and standards of good clinical research practice.
All patients signed written informed consent and the study was conducted according to local and national ethical review board approval, the Declaration of Helsinki and standards of Good Clinical Practice.
The protocols were developed in collaboration with, and approved by, an independent ethics committee, and the studies were carried out in accordance with the Declaration of Helsinki, the standards of the International Conference on Harmonization, Guideline for Good Clinical Practice and local regulations.
The study complies rigorously with data protection legislation, and will be conducted according to the principles of the Helsinki Declaration, following standards of good scientific practice.
The PBMC were isolated from two healthy volunteer donors, from whom we obtained informed consent according to the guidelines of the Declaration of Helsinki, using standard density gradient centrifugation on Lymphoprep (Nycomed, Oslo, Norway).
The study was performed according to Helsinki Declaration and standards of Good Clinical Practise.
The study was carried out in accordance with the Declaration of Helsinki's ethical standards.
The study was performed in accordance with ethical standards (Declaration of Helsinki, Human Research Ethics Committee in Lausanne).
